Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease.

Bernstein AM, Ding EL, Willett WC, Rimm EB.

J Nutr. 2012 Jan;142(1):99-104. doi: 10.3945/jn.111.148973. Epub 2011 Nov 23. Review.

2.

Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).

Sone H, Tanaka S, Tanaka S, Iimuro S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study Group..

J Clin Endocrinol Metab. 2011 Nov;96(11):3448-56. doi: 10.1210/jc.2011-0622. Epub 2011 Aug 24.

PMID:
21865372
3.

Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.

Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V.

Circulation. 2007 Jan 30;115(4):450-8. Epub 2006 Dec 26.

4.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W; Atherosclerosis Risk in Communities Study Group..

Circulation. 2001 Sep 4;104(10):1108-13.

5.

Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men.

Abdel-Maksoud MF, Eckel RH, Hamman RF, Hokanson JE.

J Clin Lipidol. 2012 Jul-Aug;6(4):374-81. doi: 10.1016/j.jacl.2012.02.011. Epub 2012 Mar 5.

PMID:
22836075
6.

Evidence that triglycerides are an independent coronary heart disease risk factor.

Cullen P.

Am J Cardiol. 2000 Nov 1;86(9):943-9. Review.

PMID:
11053704
9.
10.

Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control.

Carey VJ, Bishop L, Laranjo N, Harshfield BJ, Kwiat C, Sacks FM.

Am J Cardiol. 2010 Sep 15;106(6):757-63. doi: 10.1016/j.amjcard.2010.05.002. Epub 2010 Aug 1.

11.

Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: lipoprotein lipase genotype and plasma triglycerides as an exemplar.

Smith AJ, Palmen J, Putt W, Talmud PJ, Humphries SE, Drenos F.

Hum Mol Genet. 2010 Oct 15;19(20):3936-47. doi: 10.1093/hmg/ddq308. Epub 2010 Jul 22.

12.

Serum triglycerides and risk of coronary heart disease among Japanese men and women.

Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, Shimamoto T, Iida M, Komachi Y.

Am J Epidemiol. 2001 Mar 1;153(5):490-9.

PMID:
11226981
13.

The independent relationship between triglycerides and coronary heart disease.

Morrison A, Hokanson JE.

Vasc Health Risk Manag. 2009;5(1):89-95. Epub 2009 Apr 8. Review.

14.
16.

Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.

Patel JV, Caslake MJ, Vyas A, Cruickshank JK, Prabhakaran D, Bhatnagar D, Reddy KS, Lip GY, Mackness MI, Hughes EA, Durrington PN.

Atherosclerosis. 2010 Apr;209(2):579-84. doi: 10.1016/j.atherosclerosis.2009.10.010. Epub 2009 Oct 13.

PMID:
19922937
17.

Triglycerides and coronary heart disease: implications of recent clinical trials.

Rubins HB.

J Cardiovasc Risk. 2000 Oct;7(5):339-45. Review.

PMID:
11143764
18.

Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.

Sacks FM, Tonkin AM, Craven T, Pfeffer MA, Shepherd J, Keech A, Furberg CD, Braunwald E.

Circulation. 2002 Mar 26;105(12):1424-8.

19.
20.

Apolipoprotein C-I genotype and serum levels of triglycerides, C-reactive protein and coronary heart disease.

Olsson B, Gigante B, Mehlig K, Bergsten A, Leander K, de Faire U, Lissner L, Thelle DS, Carlsson LM.

Metabolism. 2010 Dec;59(12):1736-41. doi: 10.1016/j.metabol.2010.04.017. Epub 2010 Jul 2.

PMID:
20580041

Supplemental Content

Support Center